Delphi Management Inc /Ma/ Bristol Myers Squibb CO Transaction History

Delphi Management Inc /Ma/

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jul 11, 2023	SELL	$68.48 - $81.09 $1.48 Million - $1.75 Million	-21,549 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $43,762 - $51,016	816 Added 3.94%	21,549 $1.34 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $36,152 - $42,348	611 Added 3.04%	20,733 $1.23 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $14,548 - $15,843	235 Added 1.18%	20,122 $1.35 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $89,366 - $100,510	-1,506 Reduced 7.04%	19,887 $1.26 Million
Q3 2019 Oct 07, 2019	SELL	$42.77 - $50.71 $275,567 - $326,724	-6,443 Reduced 23.15%	21,393 $1.09 Million
Q2 2019 Aug 20, 2019	SELL	$44.62 - $49.34 $892 - $986	-20 Reduced 0.07%	27,836 $1.26 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $66,912 - $79,785	1,483 Added 5.62%	27,856 $1.33 Million
Q4 2018 Feb 22, 2019	BUY	$48.76 - $63.23 $1.29 Million - $1.67 Million	26,373 New	26,373 $1.37 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Delphi Management Inc /Ma/, based on Form 13F filings with the SEC.

Stay updated on Delphi Management Inc /Ma/ with notifications on news.